article
Issue #2 2017 – Digital version
Read the free-to-view digital version of the latest issue of European Pharmaceutical Review...
List view / Grid view
Drug delivery
article
How Panacea is paving the way for vaccine immunotherapies
29 March 2017 | By Niamh Marriott, Junior Editor
We caught up with the CEO & CSO of Panacea for the latest on vaccine immunotherapies - "As a scientist, as long as you are observant and persistent, you may come up with breakthrough discoveries"
news
Injectable drug delivery market worth US$624.50 billion by 2021
23 March 2017 | By Niamh Marriott, Junior Editor
According to a new report, the global injectable drug delivery market is projected to reach US$624.50 Billion by 2021 from US$362.38 billion in 2016...
news
Developing nanopreparation properties for use in anticancer medicines
15 March 2017 | By Steve Bremer, Managing Editor
Tumour therapy, particularly in the case of multidrug resistant cancers, could be significantly enhanced by using siRNA to down-regulate the production...
news
Biocartis and Merck partnership launch second liquid biopsy assay
15 March 2017 | By Niamh Marriott, Junior Editor
This collaboration is aimed at jointly developing and commercialising new liquid biopsy RAS biomarker tests for metastatic colorectal cancer (mCRC)...
article
Improving the consistency of MDI drug delivery
A defining characteristic of inhaled drug delivery is variability in the dose received by the patient, as a result of physiology, for example, or the technique applied during use. This variability directly affects clinical outcomes so reducing it to a minimum is an important goal for the industry...
article
Understanding the effect of API changes in pharmaceutical processing
For the pharmaceutical scientist, the journey of an active molecule from the end of its synthetic pathway and crystallisation to its ultimate site of action is a fascinating one, and one that is necessary to understand...
article
Issue #1 2017 – Digital version
Read the free-to-view digital version of the latest issue of European Pharmaceutical Review...
news
FDA to review Mylan and Biocon’s biosimilar application
17 February 2017 | By Niamh Marriott, Digital Editor
The US Food and Drug Administration (FDA) has accepted Mylan and Biocon's biologics license application for MYL-1401H, a proposed biosimilar to Neulasta...
news
Immunotherapy treatment fast-tracked under UK’s access to medicines scheme
2 February 2017 | By Niamh Marriott, Digital Editor
From today, UK patients with an incurable form of bladder cancer can access the new immunotherapy, atezolizumab, following a positive Scientific Opinion...
article
Issue #6 2016 – Digital version
Read the free-to-view digital version of the latest issue of European Pharmaceutical Review...
news
Dolomite Bio’s Single Cell RNA-Seq System accelerating cancer research
8 December 2016 | By Dolomite Bio
Researchers at The Institute of Cancer Research (ICR), London, are taking advantage of the single cell encapsulation capabilities of Dolomite Bio’s Single Cell RNA-Seq System to investigate resistance mechanisms in prostate cancer...
article
Osteomyelitis: How artificial bone grafts are filling the gap
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
We caught up with Bonesupport's CEO Richard Davies to find out how they're using artificial bone grafts to help sufferers of chronic osteomyelitis...
article
A is for Antibiotics
14 November 2016 | By Niamh Louise Marriott, Digital Content Producer
A is for Antibiotics - the first instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest news and research on the subject of antibiotics.
news
Up to 10-fold increase in assay sensitivity – discover Morffi™ at MEDICA 2016
3 November 2016 | By BBI Solutions
BBI Solutions will be showcasing its Morffi™ signal enhancement technology on Stand F26 in Hall 1 at MEDICA 2016...
